The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Janssen-Ortho; Roche/Genentech
Consulting or Advisory Role - Janssen-Ortho; Roche/Genentech
Research Funding - Janssen-Ortho
OAsIs: An international phase I trial of obinutuzumab, venetoclax plus ibrutinib in relapsed/refractory mantle cell lymphoma.
 
Steven Le Gouill
Honoraria - Janssen-Ortho; Roche/Genentech
Consulting or Advisory Role - Janssen-Ortho; Roche/Genentech
Research Funding - Janssen-Ortho (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Andrew Davies
Honoraria - Roche/Genentech
Consulting or Advisory Role - Roche/Genentech
 
Kamal Bouabdallah
Honoraria - Roche/Genentech
Consulting or Advisory Role - Roche/Genentech
 
David Chiron
No Relationships to Disclose
 
Simon Rule
No Relationships to Disclose